Guía práctica de las nuevas alternativas terapéuticas frente a SARS-CoV-2 en pacientes con inmunomoduladores de uso frecuente en dermatología by M. Viedma-Martínez, G. Gallo-Pineda, D. Jiménez-Gallo

Subjects: Get full text

[Translated article] Practical Guide to New Treatments for SARS-CoV-2 Infection in Dermatology Patients Being Treated With Common Immunomodulators by M. Viedma-Martínez, G. Gallo-Pineda, D. Jiménez-Gallo

Subjects: Get full text

Hope and fear; Paxlovid for COVID-19 treatment: A Letter to the Editor by Alireza Pouramini, Maryam Khosravian, Fatemeh Kafi, Sina Bakhshaei, Hamid Reza Jahantigh, Payam Peymani, Neda Kianpour, Majid Foroutan

Subjects: Get full text

Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study by Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Oleksandr Kamyshnyi

Subjects: Get full text

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis by Wen Wen, Chen Chen, Jiake Tang, Chunyi Wang, Mengyun Zhou, Yongran Cheng, Xiang Zhou, Qi Wu, Xingwei Zhang, Zhanhui Feng, Mingwei Wang, Qin Mao

Subjects: Get full text

Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients by Zahirah Zaharuddin, Nur Sabiha Md Hussin, Mahmathi Karuppannan

Subjects: “…Paxlovid…”
Get full text

Paxlovid (Nirmatrelvir and Ritonavir) Use in Pregnant and Lactating Woman: Current Evidence and Practice Guidelines—A Scoping Review by Prabal Chourasia, Babu Sriram Maringanti, Morgan Edwards-Fligner, Karthik Gangu, Aniesh Bobba, Abu Baker Sheikh, Rahul Shekhar

Subjects: “…paxlovid…”
Get full text

COVID-19 rebound after oral treatment in a nursing home facility: A case series by Alex P. Betrosian, Stavros M. Christou, Stavroula Kalathaki

Subjects: Get full text

Early Versus Delayed Usage of Paxlovid in Severe Omicron‐Infected Patients With Hypoxemia: A Prospective Multiple‐Center Cohort Study by Yu‐Ji Wang, Xi‐Yan Ma, Xiao‐Ying Wei, Meng‐Lan Zhang, Nan Su, Jun‐Hong Jiang, Guo‐Peng Xu, Ran Wang, Da‐Xiong Zeng

Subjects: Get full text

Efficacy and Safety of Azvudine in Patients With COVID‐19 in China: A Meta‐Analysis of Observational Studies by Tao Dong, Wentao Zhang, Tingting Wu, Yongxiang Ge, Qi Yang, Jia Xu, Yuna Liu

Subjects: Get full text

Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patients by Aaisha Shah, Adeel Nasrullah, Muhammad Ali Butt, Meilin Young

Subjects: Get full text

Should Paxlovid be prescribed for patients with severe COVID‐19 in the late course of infection? A case report by Qiang Li, Yibo He, Jin Liu, Xiaozhao Lu, Ziyou Zhou, Yu Kang, Wanying Wu, Jielan Wu, Feng Wang, Yinghao Sun, Wei Wang, Chengyi Hui, Wenting Wei, Miaoyun Wen, Jingjing Chen, Yong Liu

Subjects: Get full text

Paxlovid accelerates cartilage degeneration and senescence through activating endoplasmic reticulum stress and interfering redox homeostasis by Keyu Kong, Yongyun Chang, Hua Qiao, Chen Zhao, Xuzhuo Chen, Kewei Rong, Pu Zhang, Minghao Jin, Jingwei Zhang, Huiwu Li, Zanjing Zhai

Subjects: “…Paxlovid…”
Get full text

Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge by Maen Abdelrahim, Maen Abdelrahim, Maen Abdelrahim, Abdullah Esmail, Abdullah Esmail, Abdullah Esmail, Noor Al Saadi, Eva Zsigmond, Ebtesam Al Najjar, Doaa Bugazia, Hadeel Al-Rawi, Ayat Alsaadi, Ahmed O. Kaseb

Subjects: Get full text

Mitigating Paxlovid™-induced drug‒drug interaction toxicity: an in silico insight by Giang H. Ta, Max K. Leong

Subjects: Get full text

COVID-19 vaccination modified the effect of nirmatrelvir–ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study by Huwen Wang, Yuchen Wei, Guozhang Lin, Christopher Boyer, Katherine Min Jia, Chi Tim Hung, Xiaoting Jiang, Conglu Li, Carrie Ho Kwan Yam, Tsz Yu Chow, Yawen Wang, Shi Zhao, Zihao Guo, Kehang Li, Aimin Yang, Chris Ka Pun Mok, David S. C. Hui, Ka Chun Chong, Eng Kiong Yeoh

Subjects: “…Paxlovid…”
Get full text

Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A retrospective study by Wei Yang, Weiting Zhang, Jing Zhou, Xinyue Ma, Changsong Wang, Mingyan Zhao, Kaijiang Yu

Subjects: Get full text

The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2 by Hanul Park, Young Joon Park, Hye Young Lee, Mi Yu, Yeong-Jun Song, Sang Eun Lee, Ji-Joo Lee, Eun-Sol Lee, Yeonjung Kim

Subjects: Get full text

Pharmacokinetic analysis of placental transfer of ritonavir as a component of paxlovid using microdialysis in pregnant rats by Chung-Kai Sun, Wan-Hsin Lee, Muh-Hwa Yang, Tung-Hu Tsai

Subjects: Get full text

Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID^®) with Concomitant Medications in Real-World Clinical Settings by Petra Zatovkaňuková, Dalibor Veselý, Jiří Slíva

Subjects: Get full text